Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.
Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, L Whitehouse J, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW. Barr HL, et al. J Cyst Fibros. 2017 Mar;16(2):230-238. doi: 10.1016/j.jcf.2016.10.005. Epub 2016 Oct 20. J Cyst Fibros. 2017. PMID: 27773591 Free PMC article.
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments.
Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW. Barr HL, et al. J Cyst Fibros. 2017 Nov;16(6):e21. doi: 10.1016/j.jcf.2017.09.008. Epub 2017 Oct 25. J Cyst Fibros. 2017. PMID: 29079141 Free article. No abstract available.
Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis.
Webb K, Cámara M, Zain NMM, Halliday N, Bruce KD, Nash EF, Whitehouse JL, Knox A, Forrester D, Smyth AR, Williams P, Fogarty A, Barr HL. Webb K, et al. Among authors: barr hl. J Cyst Fibros. 2022 Jul;21(4):626-629. doi: 10.1016/j.jcf.2021.08.030. Epub 2021 Sep 11. J Cyst Fibros. 2022. PMID: 34518117 Free article.
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis.
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: barr hl. J Cyst Fibros. 2022 Mar;21(2):323-331. doi: 10.1016/j.jcf.2021.09.007. Epub 2021 Sep 23. J Cyst Fibros. 2022. PMID: 34565705 Free article.
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI).
Yule A, Ng C, Recto A, Lockwood F, Dellschaft NS, Hoad CL, Zagoya C, Mainz JG, Major G, Barr HL, Gowland PA, Stewart I, Marciani L, Spiller RC, Smyth AR. Yule A, et al. Among authors: barr hl. J Cyst Fibros. 2024 Sep;23(5):984-990. doi: 10.1016/j.jcf.2024.08.001. Epub 2024 Sep 5. J Cyst Fibros. 2024. PMID: 39242338 Free article.
Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.
Forrester DL, Knox AJ, Smyth AR, Barr HL, Simms R, Pacey SJ, Pavord ID, Honeybourne D, Dewar J, Clayton A, Fogarty AW. Forrester DL, et al. Among authors: barr hl. Pediatr Pulmonol. 2016 Mar;51(3):253-7. doi: 10.1002/ppul.23370. Epub 2015 Dec 27. Pediatr Pulmonol. 2016. PMID: 26709241 Clinical Trial.
Real-World Adherence Among Adults With Cystic Fibrosis Is Low: A Retrospective Analysis of the CFHealthHub Digital Learning Health System.
Hoo ZH, Totton N, Waterhouse S, Lewis J, Girling C, Bradburn M, Arden MA, Whelan P, Ainsworth J, Dawson S, Millward S, Barnett K, Dewar J, Barr HL, Saini G, Shepherd E, Carroll M, Allenby MI, Daniels TV, Nightingale JA, Lowther M, Carolan C, Clarke C, Szczepanski R, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Hoo ZH, et al. Among authors: barr hl. Chest. 2021 Dec;160(6):2061-2065. doi: 10.1016/j.chest.2021.06.039. Epub 2021 Jun 26. Chest. 2021. PMID: 34186037 No abstract available.
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331].
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: barr hl. J Cyst Fibros. 2022 Sep;21(5):893-897. doi: 10.1016/j.jcf.2022.07.011. Epub 2022 Jul 28. J Cyst Fibros. 2022. PMID: 35907767 Free article. No abstract available.
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis.
Zain NMM, Webb K, Stewart I, Halliday N, Barrett DA, Nash EF, Whitehouse JL, Honeybourne D, Smyth AR, Forrester DL, Knox AJ, Williams P, Fogarty A, Cámara M, Bruce KD, Barr HL. Zain NMM, et al. Among authors: barr hl. J Med Microbiol. 2021 Oct;70(10):001420. doi: 10.1099/jmm.0.001420. J Med Microbiol. 2021. PMID: 34596013 Free PMC article.
Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis.
Webb K, Zain NMM, Stewart I, Fogarty A, Nash EF, Whitehouse JL, Smyth AR, Lilley AK, Knox A, Williams P, Cámara M, Bruce K, Barr HL. Webb K, et al. Among authors: barr hl. J Med Microbiol. 2022 Feb;71(2):001481. doi: 10.1099/jmm.0.001481. J Med Microbiol. 2022. PMID: 35113780 Free PMC article.
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.
Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, Van Braeckel E, Wainwright CE, Watson D, Ahluwalia N, Bruinsma BG, Harris C, Lam AP, Lou Y, Moskowitz SM, Tian S, Yuan J, Waltz D, Mall MA; VX18-445-109 study group. Sutharsan S, et al. Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20. Lancet Respir Med. 2022. PMID: 34942085 Clinical Trial.
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.
Barr HL, Cámara M, Barrett D, Williams P, Forrester D, Smyth A, Honeybourne D, Whitehouse J, Nash E, Dewar J, Knox A, Fogarty AW. Barr HL, et al. ERJ Open Res. 2017 Aug 25;3(3):00057-2017. doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul. ERJ Open Res. 2017. PMID: 28852645 Free PMC article.
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group. Davies JC, et al. N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334693 Free PMC article. Clinical Trial.
Ethical planning for an influenza pandemic.
Barr HL, Macfarlane JT, Macgregor O, Foxwell R, Buswell V, Lim WS. Barr HL, et al. Clin Med (Lond). 2008 Feb;8(1):49-52. doi: 10.7861/clinmedicine.8-1-49. Clin Med (Lond). 2008. PMID: 18335669 Free PMC article.
Practical mastitis control in the field.
Heider LE, Barr HL. Heider LE, et al. Among authors: barr hl. J Am Vet Med Assoc. 1977 May 15;170(10 Pt 2):1236-8. J Am Vet Med Assoc. 1977. PMID: 559664
Personality.
Klein GS, Barr HL, Wolitzky DL. Klein GS, et al. Among authors: barr hl. Annu Rev Psychol. 1967;18:467-560. doi: 10.1146/annurev.ps.18.020167.002343. Annu Rev Psychol. 1967. PMID: 5333430 Review. No abstract available.
INDIVIDUAL DIFFERENCES IN THE RECALL OF A DRUG EXPERIENCE.
PAUL IH, LANGS RJ, BARR HL. PAUL IH, et al. Among authors: barr hl. J Nerv Ment Dis. 1965 Feb;140:132-45. doi: 10.1097/00005053-196502000-00003. J Nerv Ment Dis. 1965. PMID: 14300215 No abstract available.